ONCOSCREEN Project
@oncoscreen-project.bsky.social
A European “shield” against colorectal cancer based on novel, more precise and affordable risk-based screening methods and viable policy pathways
Pinned
👋Hello and welcome to ONCOSCREEN!
@oncoscreen seeks to develop new methods and technologies for colorectal cancer screening and its early detection.
Below is a thread🧵outlining all you need to know about #ONCOSCREEN and what the project involves👇
@oncoscreen seeks to develop new methods and technologies for colorectal cancer screening and its early detection.
Below is a thread🧵outlining all you need to know about #ONCOSCREEN and what the project involves👇
Today we attended the 3rd Annual Prevention & Screening Cluster Meeting for #ONCOSCREEN!
Experts came together to share insights, discuss innovations & strengthen collaboration in cancer prevention and early detection. 🩺💡
#CancerPrevention #EarlyDetection #HealthcareInnovation
Experts came together to share insights, discuss innovations & strengthen collaboration in cancer prevention and early detection. 🩺💡
#CancerPrevention #EarlyDetection #HealthcareInnovation
November 20, 2025 at 3:25 PM
Today we attended the 3rd Annual Prevention & Screening Cluster Meeting for #ONCOSCREEN!
Experts came together to share insights, discuss innovations & strengthen collaboration in cancer prevention and early detection. 🩺💡
#CancerPrevention #EarlyDetection #HealthcareInnovation
Experts came together to share insights, discuss innovations & strengthen collaboration in cancer prevention and early detection. 🩺💡
#CancerPrevention #EarlyDetection #HealthcareInnovation
🔤 ABCs of #ONCOSCREEN
H = Hackathons
Hackathons spark rapid innovation—bringing developers, clinicians, researchers & patients together to prototype new ideas that can improve CRC screening and early detection.
Collaboration + innovation = impact. 🚀
H = Hackathons
Hackathons spark rapid innovation—bringing developers, clinicians, researchers & patients together to prototype new ideas that can improve CRC screening and early detection.
Collaboration + innovation = impact. 🚀
November 14, 2025 at 4:25 PM
🔤 ABCs of #ONCOSCREEN
H = Hackathons
Hackathons spark rapid innovation—bringing developers, clinicians, researchers & patients together to prototype new ideas that can improve CRC screening and early detection.
Collaboration + innovation = impact. 🚀
H = Hackathons
Hackathons spark rapid innovation—bringing developers, clinicians, researchers & patients together to prototype new ideas that can improve CRC screening and early detection.
Collaboration + innovation = impact. 🚀
🔤 ABCs of #ONCOSCREEN
G = Gastroenterology
Gastroenterologists are at the heart of CRC prevention, combining clinical expertise, innovation & patient care to improve screening and outcomes across Europe. 💙
G = Gastroenterology
Gastroenterologists are at the heart of CRC prevention, combining clinical expertise, innovation & patient care to improve screening and outcomes across Europe. 💙
October 13, 2025 at 9:10 AM
🔤 ABCs of #ONCOSCREEN
G = Gastroenterology
Gastroenterologists are at the heart of CRC prevention, combining clinical expertise, innovation & patient care to improve screening and outcomes across Europe. 💙
G = Gastroenterology
Gastroenterologists are at the heart of CRC prevention, combining clinical expertise, innovation & patient care to improve screening and outcomes across Europe. 💙
📢 New Publication: A Decision Support Model for Colorectal Cancer Screening
Our latest research introduces a personalised model that tailors CRC screening based on individual risk factors.
Read more here 👉 oncoscreen.health/2025/09/23/p...
Our latest research introduces a personalised model that tailors CRC screening based on individual risk factors.
Read more here 👉 oncoscreen.health/2025/09/23/p...
October 2, 2025 at 1:50 PM
📢 New Publication: A Decision Support Model for Colorectal Cancer Screening
Our latest research introduces a personalised model that tailors CRC screening based on individual risk factors.
Read more here 👉 oncoscreen.health/2025/09/23/p...
Our latest research introduces a personalised model that tailors CRC screening based on individual risk factors.
Read more here 👉 oncoscreen.health/2025/09/23/p...
🔍 Partner Insights Series: Catalink Spotlight
We’re excited to share our latest video in the ONCOSCREEN Partner Insights series, this time featuring Catalink Ltd!
Watch the full video here:
👉 youtu.be/7w-n_hGOJeM
We’re excited to share our latest video in the ONCOSCREEN Partner Insights series, this time featuring Catalink Ltd!
Watch the full video here:
👉 youtu.be/7w-n_hGOJeM
Project Partner Spotlight: Catalink
YouTube video by ONCOSCREEN
youtu.be
September 25, 2025 at 9:57 AM
🔍 Partner Insights Series: Catalink Spotlight
We’re excited to share our latest video in the ONCOSCREEN Partner Insights series, this time featuring Catalink Ltd!
Watch the full video here:
👉 youtu.be/7w-n_hGOJeM
We’re excited to share our latest video in the ONCOSCREEN Partner Insights series, this time featuring Catalink Ltd!
Watch the full video here:
👉 youtu.be/7w-n_hGOJeM
🔤 ABCs of #ONCOSCREEN
F = Fundamental Rights in Healthcare
Everyone deserves equal, timely & effective access to care. Our approach to CRC screening puts fairness, accessibility & patient rights at the core.
#CancerPrevention #HealthcareForAll #MissionCancerEU
F = Fundamental Rights in Healthcare
Everyone deserves equal, timely & effective access to care. Our approach to CRC screening puts fairness, accessibility & patient rights at the core.
#CancerPrevention #HealthcareForAll #MissionCancerEU
August 28, 2025 at 11:58 AM
🔤 ABCs of #ONCOSCREEN
F = Fundamental Rights in Healthcare
Everyone deserves equal, timely & effective access to care. Our approach to CRC screening puts fairness, accessibility & patient rights at the core.
#CancerPrevention #HealthcareForAll #MissionCancerEU
F = Fundamental Rights in Healthcare
Everyone deserves equal, timely & effective access to care. Our approach to CRC screening puts fairness, accessibility & patient rights at the core.
#CancerPrevention #HealthcareForAll #MissionCancerEU
🚀 NEW: #ONCOSCREEN Partner Spotlight!
Meet Rosenbaum Group—clinical research experts in the CEE region, supporting trials for over 1,100 patients across 🇬🇷🇭🇺🇸🇰🇨🇿🇧🇬.
Fast, high-quality, and patient-focused.
🎥 Watch Ep.1 👉 youtu.be/6ljfhQiMHxI
Meet Rosenbaum Group—clinical research experts in the CEE region, supporting trials for over 1,100 patients across 🇬🇷🇭🇺🇸🇰🇨🇿🇧🇬.
Fast, high-quality, and patient-focused.
🎥 Watch Ep.1 👉 youtu.be/6ljfhQiMHxI
August 12, 2025 at 8:01 AM
🚀 NEW: #ONCOSCREEN Partner Spotlight!
Meet Rosenbaum Group—clinical research experts in the CEE region, supporting trials for over 1,100 patients across 🇬🇷🇭🇺🇸🇰🇨🇿🇧🇬.
Fast, high-quality, and patient-focused.
🎥 Watch Ep.1 👉 youtu.be/6ljfhQiMHxI
Meet Rosenbaum Group—clinical research experts in the CEE region, supporting trials for over 1,100 patients across 🇬🇷🇭🇺🇸🇰🇨🇿🇧🇬.
Fast, high-quality, and patient-focused.
🎥 Watch Ep.1 👉 youtu.be/6ljfhQiMHxI
🏛️ How does #ONCOSCREEN work with governments to improve colorectal cancer screening?
By embedding innovation directly into public systems, the project is aligning tech, policy & practice across Europe.
Read the blog 👉 oncoscreen.health/2025/08/01/h...
By embedding innovation directly into public systems, the project is aligning tech, policy & practice across Europe.
Read the blog 👉 oncoscreen.health/2025/08/01/h...
How ONCOSCREEN Operates In and Through Governmental Departments – oncoscreen.health
oncoscreen.health
August 6, 2025 at 10:28 AM
🏛️ How does #ONCOSCREEN work with governments to improve colorectal cancer screening?
By embedding innovation directly into public systems, the project is aligning tech, policy & practice across Europe.
Read the blog 👉 oncoscreen.health/2025/08/01/h...
By embedding innovation directly into public systems, the project is aligning tech, policy & practice across Europe.
Read the blog 👉 oncoscreen.health/2025/08/01/h...
🗣️ From co-creation workshops to national dialogues, discover how patients are helping shape a more inclusive, effective, and human-centered approach to CRC prevention.
📖 Full Blog here:https://oncoscreen.health/2025/07/10/patient-engagement-within-oncoscreen/
📖 Full Blog here:https://oncoscreen.health/2025/07/10/patient-engagement-within-oncoscreen/
July 15, 2025 at 10:06 AM
🗣️ From co-creation workshops to national dialogues, discover how patients are helping shape a more inclusive, effective, and human-centered approach to CRC prevention.
📖 Full Blog here:https://oncoscreen.health/2025/07/10/patient-engagement-within-oncoscreen/
📖 Full Blog here:https://oncoscreen.health/2025/07/10/patient-engagement-within-oncoscreen/
🚨 Big ideas for the future of colorectal cancer screening!
The #ONCOSCREEN Plenary & Living Labs Day sparked key discussions on tech, policy & patient-centered innovation in CRC screening.
Catch the highlights 👉 oncoscreen.health/2025/06/17/o...
The #ONCOSCREEN Plenary & Living Labs Day sparked key discussions on tech, policy & patient-centered innovation in CRC screening.
Catch the highlights 👉 oncoscreen.health/2025/06/17/o...
ONCOSCREEN Plenary: Living Labs Day Sparks Key Discussions on the Future of CRC Screening – oncoscreen.health
oncoscreen.health
July 7, 2025 at 11:19 AM
🚨 Big ideas for the future of colorectal cancer screening!
The #ONCOSCREEN Plenary & Living Labs Day sparked key discussions on tech, policy & patient-centered innovation in CRC screening.
Catch the highlights 👉 oncoscreen.health/2025/06/17/o...
The #ONCOSCREEN Plenary & Living Labs Day sparked key discussions on tech, policy & patient-centered innovation in CRC screening.
Catch the highlights 👉 oncoscreen.health/2025/06/17/o...
📊 How can policymakers make smarter, data-driven decisions about colorectal cancer (CRC) screening?
This Blog explores how Onco-Evida, was designed with input from public health experts, and built to turn complex data into actionable knowledge.
More: oncoscreen.health/2025/06/17/o...
This Blog explores how Onco-Evida, was designed with input from public health experts, and built to turn complex data into actionable knowledge.
More: oncoscreen.health/2025/06/17/o...
June 23, 2025 at 1:24 PM
📊 How can policymakers make smarter, data-driven decisions about colorectal cancer (CRC) screening?
This Blog explores how Onco-Evida, was designed with input from public health experts, and built to turn complex data into actionable knowledge.
More: oncoscreen.health/2025/06/17/o...
This Blog explores how Onco-Evida, was designed with input from public health experts, and built to turn complex data into actionable knowledge.
More: oncoscreen.health/2025/06/17/o...
✨ NEW BLOG ✨
How can we make colorectal cancer screening smarter, safer & more accessible?
#ONCOSCREEN is building a next-gen system with AI, co-design & privacy-first architecture—shaped by clinicians, patients & policymakers.
👉 oncoscreen.health/2025/05/28/i...
#DigitalHealth #MissionCancerEU
How can we make colorectal cancer screening smarter, safer & more accessible?
#ONCOSCREEN is building a next-gen system with AI, co-design & privacy-first architecture—shaped by clinicians, patients & policymakers.
👉 oncoscreen.health/2025/05/28/i...
#DigitalHealth #MissionCancerEU
June 5, 2025 at 9:56 AM
✨ NEW BLOG ✨
How can we make colorectal cancer screening smarter, safer & more accessible?
#ONCOSCREEN is building a next-gen system with AI, co-design & privacy-first architecture—shaped by clinicians, patients & policymakers.
👉 oncoscreen.health/2025/05/28/i...
#DigitalHealth #MissionCancerEU
How can we make colorectal cancer screening smarter, safer & more accessible?
#ONCOSCREEN is building a next-gen system with AI, co-design & privacy-first architecture—shaped by clinicians, patients & policymakers.
👉 oncoscreen.health/2025/05/28/i...
#DigitalHealth #MissionCancerEU
Day 4 of the #ONCOSCREEN Plenary is all about the ONCOLOGICAL Living Labs! 🤝 Our partners have gathered for an interactive session led by industry experts
🔹 Focus on CRC policy, financing & citizen engagement
🔹 Next steps: ONCOTHON & future Living Labs planning!
🔹 Focus on CRC policy, financing & citizen engagement
🔹 Next steps: ONCOTHON & future Living Labs planning!
May 22, 2025 at 7:04 AM
Day 4 of the #ONCOSCREEN Plenary is all about the ONCOLOGICAL Living Labs! 🤝 Our partners have gathered for an interactive session led by industry experts
🔹 Focus on CRC policy, financing & citizen engagement
🔹 Next steps: ONCOTHON & future Living Labs planning!
🔹 Focus on CRC policy, financing & citizen engagement
🔹 Next steps: ONCOTHON & future Living Labs planning!
🔬 Wrapping up Day 3 of the #ONCOSCREEN Plenary with tool demos & real-world testing!
🛠️ From ONCOCRISPR to ONCOVOC, partners showcased diagnostic tools & AI platforms
✅ Evaluation led by ICCS & POLA ensured tools meet user needs
Collaboration in action! 🚀
🛠️ From ONCOCRISPR to ONCOVOC, partners showcased diagnostic tools & AI platforms
✅ Evaluation led by ICCS & POLA ensured tools meet user needs
Collaboration in action! 🚀
May 21, 2025 at 2:35 PM
🔬 Wrapping up Day 3 of the #ONCOSCREEN Plenary with tool demos & real-world testing!
🛠️ From ONCOCRISPR to ONCOVOC, partners showcased diagnostic tools & AI platforms
✅ Evaluation led by ICCS & POLA ensured tools meet user needs
Collaboration in action! 🚀
🛠️ From ONCOCRISPR to ONCOVOC, partners showcased diagnostic tools & AI platforms
✅ Evaluation led by ICCS & POLA ensured tools meet user needs
Collaboration in action! 🚀
🎯 Day 3 of the #ONCOSCREEN Plenary kicks off with our Oncological Living Lab on CRC Tools!
Patients, clinicians & policymakers are testing ONCOSCREEN innovations hands-on—from #AI-powered diagnostics to privacy-preserving platforms.
Real users. Real feedback. Real impact. 🔍💬
Patients, clinicians & policymakers are testing ONCOSCREEN innovations hands-on—from #AI-powered diagnostics to privacy-preserving platforms.
Real users. Real feedback. Real impact. 🔍💬
May 21, 2025 at 7:56 AM
🎯 Day 3 of the #ONCOSCREEN Plenary kicks off with our Oncological Living Lab on CRC Tools!
Patients, clinicians & policymakers are testing ONCOSCREEN innovations hands-on—from #AI-powered diagnostics to privacy-preserving platforms.
Real users. Real feedback. Real impact. 🔍💬
Patients, clinicians & policymakers are testing ONCOSCREEN innovations hands-on—from #AI-powered diagnostics to privacy-preserving platforms.
Real users. Real feedback. Real impact. 🔍💬
This afternoon at the #ONCOSCREEN Plenary
🛡️ Risk mitigation strategies for clinical trials with UMC Mainz & @FiralisGroup
🔧 System architecture finalisation with ICCS
💼 IPR & exploitation planning with @exus_AILabs
🗣️ Citizen awareness workshop led by Europacolon
🛡️ Risk mitigation strategies for clinical trials with UMC Mainz & @FiralisGroup
🔧 System architecture finalisation with ICCS
💼 IPR & exploitation planning with @exus_AILabs
🗣️ Citizen awareness workshop led by Europacolon
May 20, 2025 at 3:18 PM
This afternoon at the #ONCOSCREEN Plenary
🛡️ Risk mitigation strategies for clinical trials with UMC Mainz & @FiralisGroup
🔧 System architecture finalisation with ICCS
💼 IPR & exploitation planning with @exus_AILabs
🗣️ Citizen awareness workshop led by Europacolon
🛡️ Risk mitigation strategies for clinical trials with UMC Mainz & @FiralisGroup
🔧 System architecture finalisation with ICCS
💼 IPR & exploitation planning with @exus_AILabs
🗣️ Citizen awareness workshop led by Europacolon
Day 2 of the #ONCOSCREEN Plenary is off to a strong start in Kaunas! 🌤️
This morning, we’re diving into:
🔹 Dissemination, communication & impact strategies with @CarrCommsLtd
🔹 Clinical trial design & validation insights lead by @FiralisGroup
Stay tuned for more!
This morning, we’re diving into:
🔹 Dissemination, communication & impact strategies with @CarrCommsLtd
🔹 Clinical trial design & validation insights lead by @FiralisGroup
Stay tuned for more!
May 20, 2025 at 7:57 AM
Day 2 of the #ONCOSCREEN Plenary is off to a strong start in Kaunas! 🌤️
This morning, we’re diving into:
🔹 Dissemination, communication & impact strategies with @CarrCommsLtd
🔹 Clinical trial design & validation insights lead by @FiralisGroup
Stay tuned for more!
This morning, we’re diving into:
🔹 Dissemination, communication & impact strategies with @CarrCommsLtd
🔹 Clinical trial design & validation insights lead by @FiralisGroup
Stay tuned for more!
🎓 The 2nd ONCOSCREEN Plenary Meeting kicks off in Kaunas with a deep dive into cutting-edge research at LSMU! From nuclear medicine to regenerative therapies, today’s site visit showcases how Lithuanian science is shaping the future of cancer screening.
May 19, 2025 at 9:42 AM
🎓 The 2nd ONCOSCREEN Plenary Meeting kicks off in Kaunas with a deep dive into cutting-edge research at LSMU! From nuclear medicine to regenerative therapies, today’s site visit showcases how Lithuanian science is shaping the future of cancer screening.
#ONCOSCREEN's next Plenary Meeting is coming up!
Our partners are preparing to travel to Kaunas, Lithuania on May19-22 for the second Plenary of the project.
This will be a great opportunity to share progress updates and lay the groundwork for the next phase.
Our partners are preparing to travel to Kaunas, Lithuania on May19-22 for the second Plenary of the project.
This will be a great opportunity to share progress updates and lay the groundwork for the next phase.
May 6, 2025 at 12:04 PM
#ONCOSCREEN's next Plenary Meeting is coming up!
Our partners are preparing to travel to Kaunas, Lithuania on May19-22 for the second Plenary of the project.
This will be a great opportunity to share progress updates and lay the groundwork for the next phase.
Our partners are preparing to travel to Kaunas, Lithuania on May19-22 for the second Plenary of the project.
This will be a great opportunity to share progress updates and lay the groundwork for the next phase.
Some of our project partners who proudly represented the Oncoscreen Project at the 1st Styrian Run Against Cancer on April 26th, 2025! Organised by the Comprehensive Cancer Center (CCC) Graz at Universitätsklinikum Landeskrankenhaus.
Learn more 👉 run-against-cancer.at
Learn more 👉 run-against-cancer.at
April 30, 2025 at 8:32 AM
Some of our project partners who proudly represented the Oncoscreen Project at the 1st Styrian Run Against Cancer on April 26th, 2025! Organised by the Comprehensive Cancer Center (CCC) Graz at Universitätsklinikum Landeskrankenhaus.
Learn more 👉 run-against-cancer.at
Learn more 👉 run-against-cancer.at
✳️ #ONCOSCREEN Introduction series ✳️
Our next partner is the Hellenic Society of Gastrointestinal Oncology
➡️ Learn more about HSGO: digestiveoncology.org.gr/en/
Our next partner is the Hellenic Society of Gastrointestinal Oncology
➡️ Learn more about HSGO: digestiveoncology.org.gr/en/
April 17, 2025 at 3:20 PM
✳️ #ONCOSCREEN Introduction series ✳️
Our next partner is the Hellenic Society of Gastrointestinal Oncology
➡️ Learn more about HSGO: digestiveoncology.org.gr/en/
Our next partner is the Hellenic Society of Gastrointestinal Oncology
➡️ Learn more about HSGO: digestiveoncology.org.gr/en/
🔬 INNOVATE TO TRANSFORM HEALTHCARE!
#ONCOSCREEN is excited to support two leading conferences at the intersection of AI, cybersecurity, and digital transformation.
#ONCOSCREEN is excited to support two leading conferences at the intersection of AI, cybersecurity, and digital transformation.
April 9, 2025 at 2:00 PM
🔬 INNOVATE TO TRANSFORM HEALTHCARE!
#ONCOSCREEN is excited to support two leading conferences at the intersection of AI, cybersecurity, and digital transformation.
#ONCOSCREEN is excited to support two leading conferences at the intersection of AI, cybersecurity, and digital transformation.
Fear of a cancer diagnosis is a significant barrier to CRC screening uptake, with only 41% participation last year. Early detection is crucial, as bowel cancer is one of the most treatable forms when caught early. Learn more: ow.ly/6PjA50Vt0Mx
Study suggests fear of results contributes to low bowel cancer screening uptake
2,500 people are diagnosed with bowel cancer every year in Ireland, and about 1,000 die
ow.ly
April 2, 2025 at 11:16 AM
Fear of a cancer diagnosis is a significant barrier to CRC screening uptake, with only 41% participation last year. Early detection is crucial, as bowel cancer is one of the most treatable forms when caught early. Learn more: ow.ly/6PjA50Vt0Mx
🔤 The A-Z of #ONCOSCREEN 🔤
D is for Data Anonymisation
Data anonymisation is a critical process we employ to protect individuals' identities by removing personally identifiable information from datasets.
Find out more:https://oncoscreen.health/
D is for Data Anonymisation
Data anonymisation is a critical process we employ to protect individuals' identities by removing personally identifiable information from datasets.
Find out more:https://oncoscreen.health/
April 1, 2025 at 11:37 AM
🔤 The A-Z of #ONCOSCREEN 🔤
D is for Data Anonymisation
Data anonymisation is a critical process we employ to protect individuals' identities by removing personally identifiable information from datasets.
Find out more:https://oncoscreen.health/
D is for Data Anonymisation
Data anonymisation is a critical process we employ to protect individuals' identities by removing personally identifiable information from datasets.
Find out more:https://oncoscreen.health/
🚀 Strategies to Mitigate Financial Barriers in Colorectal Cancer Screening
In our latest blog, we explore innovative approaches to reduce financial obstacles and ensure equitable access to early detection and care.
Read the full article: ow.ly/eeIR50VpV3V
In our latest blog, we explore innovative approaches to reduce financial obstacles and ensure equitable access to early detection and care.
Read the full article: ow.ly/eeIR50VpV3V
March 27, 2025 at 5:17 PM
🚀 Strategies to Mitigate Financial Barriers in Colorectal Cancer Screening
In our latest blog, we explore innovative approaches to reduce financial obstacles and ensure equitable access to early detection and care.
Read the full article: ow.ly/eeIR50VpV3V
In our latest blog, we explore innovative approaches to reduce financial obstacles and ensure equitable access to early detection and care.
Read the full article: ow.ly/eeIR50VpV3V